All News

When I looked back on calendars and journals from my time with cancer, I was surprised to see that it was incredibly mundane.

The development of new or worsening anemia did not decrease Jakafi’s efficacy in treating primary or secondary myelofibrosis.

One expert explains why double autologous stem cell transplantation is a viable alternative to back-to-back transplant in high-risk multiple myeloma.

Patients with lung cancer may have personalized treatment options after biomarker testing, an expert said at the CURE® Educated Patient® Lung Cancer Summit.

As a cancer survivor, I realize that life doesn’t always go the way we think it will, but it doesn’t erase the guilt.

Summer is time to pay particular attention to skin issues, including for patients with cancer undergoing treatments.

Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma tended to be more likely to stay on treatment and experience fewer heart toxicities with Calquence or Brukinsa.

Treatment for lung cancer has changed significantly with immunotherapy, an expert said during the CURE® Educated Patient® Lung Cancer Summit.

Are cancer vaccines the new frontier in oncology? Experts and patients weigh in from the front lines.

Having my metastatic breast cancer experience turned into a piece of art was such a meaningful opportunity.

Leaning on spiritual belief may strengthen patients' life purposes, but for many, it's common to temporarily loosen their grip on faith after a cancer diagnosis.

Staying positive while receiving cancer treatment for non-Hodgkin lymphoma helped me feel grateful for happy moments.

Patients who received systemic therapy at the end of life did not have longer overall survival averages than those who did not receive therapy at end of life.

The Food and Drug Administration approved Keytruda plus chemotherapy, followed by single-agent Keytruda for primary advanced or recurrent endometrial cancer.

Experiencing losing a friend to cancer in the cancer community is never easy, but it’s OK to allow your heart to break.

Data show that patients’ multiple myeloma still fails to progress if patients receive less-frequent Tecvayli.

Approximately half of the patients with MDS who responded to treatment with Rytelo went a year without needing a blood transfusion, one expert explained.

Increased awareness and support may be one of the many ways to help decrease the impact of disparities in multiple myeloma.

Medical school didn't teach me how to help patients find hope during tough times.

To ensure best outcomes, patients with chronic myeloid leukemia should maintain frequent communication with their care teams — even between appointments.

Within the genitourinary cancer space, there have been many treatment advances over the past year.

Most — though not all — side effects from chronic myeloid leukemia treatment improve over time, an expert said.

The FDA approved Blincyto for patients aged one month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.

The FDA approved Imfinzi plus carboplatin and paclitaxel followed by Imfinzi alone in patients with primary advanced or recurrent dMMR endometrial cancer.

As part of the CURE® Educated Patient® Summit, one expert reviewed the landscape of bispecific antibodies, such as Tecvayli, for multiple myeloma.

After having breast cancer, I worked on learning to accept and love myself.

From Kate Middleton giving an update on her cancer treatment to Kevin Jonas’ skin cancer surgery, here’s what’s happening in the oncology space this week.